- Lilly’s Alzheimer’s drug donanemab succeeds in PhIII trial – Endpoints News Endpoints News
- Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial CNBC
- Experimental Alzheimer’s drug slows cognitive declines in large trial, drugmaker Eli Lilly says CNN
- Lilly’s Donanemab Significantly Slowed Cognitive and Functional Decline in Phase 3 Study of Early Alzheimer’s Disease PR Newswire
- Lilly drug slows Alzheimer’s progression by 35% in trial Reuters
- View Full Coverage on Google News
Noutati
-
Cata prostie incape intr-un papuc? | 11 ian. 2009
-
Aproximativ 18 milioane de cetăţeni cu drept de vot sunt aşteptaţi la urne pe 30 noiembrie | 28 nov. 2008
-
Columbia students caught between graduation celebrations and protests – The Washington Post | 28 apr. 2024
-
Train derailment at Arizona-New Mexico border, Interstate 40 closed – USA TODAY | 28 apr. 2024
-
Zendaya’s ‘Challengers’ Smash at Box Office, Audience Reviews More Mixed – TMZ | 28 apr. 2024
-
SpaceX launches Falcon 9 rocket on record-tying 20th mission – Space.com | 28 apr. 2024
-
Jerod Mayo on Patriots’ quarterback position: „We have a very strong room” – NBC s | 28 apr. 2024
-
Hamas Releases Video of Two More Hostages – The New York Times | 28 apr. 2024